ESR1 and hepatocellular carcinoma: Its expression was found to negatively interact with the size and stage of HCC tumors in a genome-wide expression study, commensurate with preclinical findings revealing that ESR1 deficiency promotes tumorigenesis and the progression of HCC [38,39,40,41].